Loading provider…
Loading provider…
Hematology & Oncology Physician in San Antonio, TX
NPI: 1174608509HQ Phone
Get MD Athanassios's Phone Numberphone_androidMobile
Get MD Athanassios's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardPA State Medical License
TX State Medical License
OH State Medical License
PA State Medical License
2005 - 2026
TX State Medical License
2011 - 2026
IL State Medical License
2000 - 2005
CT State Medical License
1997 - 2000
Yale-New Haven Medical Center
Fellowship • Medical Oncology
Until 1999
Icahn School of Medicine at Mount Sinai/Beth Israel
Residency • Internal Medicine
1994 - 1997
University of Athens
Medical School
Until 1990
Induced Bias Due to Crossover Within Randomized Controlled Trials in Surgical Oncology: A Meta-regression Analysis of Minimally Invasive versus Open Surgery for the Treatment of Gastrointestinal Cancer.
Authors: George Garas, Sheraz Markar, George Malietzis, Hutan Ashrafian, George Hanna, Emmanouil Zacharakis, Long Jiao, Athanassios Argiris, Ara Darzi, Thanos Athanasiou
Publication Date: 2017-07-27
Authors: Arnab Chakravarti, Marshall Levine, Jill Gilbert, Missak Haigentz, Arlene Forastiere, Nabil Saba, Charles Schneider, Panayiotis Savvides, Harlan Pinto, Chukwuemeka Ikpeazu, James Ohr
Journal: J Clin Oncol
Publication Date: 2019-10-16
A phase II study of the halichondrin B analog, E7389, in patients (pts) with advanced non-small cell lung cancer (NSCLC) previously treated with a taxane. A California Consortium/University of Pittsburgh/University of Chicago NCI/CTEP sponsored trial.
Authors: Barbara Gitlitz, Philip Hoffman, Chandra Belani
Publication Date: 2009-05
Lead Sponsor: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: Docetaxel, DRUG: Buparlisib, DRUG: Buparlisib matching placebo
Lead Sponsor: Athanassios Argiris
Collaborators: University of Pittsburgh, University of North Carolina, Chapel Hill
Intervention / Treatment: DRUG: Postoperative Radiotherapy and Panitumumab
Lead Sponsor: Eastern Cooperative Oncology Group
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: laboratory biomarker analysis, OTHER: immunohistochemistry staining method, GENETIC: gene expression analysis, GENETIC: in situ hybridization